Sfoglia per Rivista
Current therapeutic options for multiple myeloma.
1996-01-01 Pileri A; Palumbo A; Boccadoro M
Current therapeutic options for multiple myeloma.
1996-01-01 PILERI A ;PALUMBO A ;BOCCADORO M
Cyclic neutropenia and severe hypogammaglobulinemia in a patient with excess of CD8-positive T lymphocytes: response to G-CSF therapy.
1993-01-01 FERRERO D ;PREGNO P ;OMEDÈ P ;DIANZANI U ;CARBONE A ;DI CELLE PF ;GALLO E
Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma.
1994-01-01 Palumbo A; Boccadoro M; Triolo S; Bruno B; Pileri A
Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma.
1994-01-01 PALUMBO A ;BOCCADORO M ;BRUNO B ;TRIOLO S ;PILERI A
Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors.
1997-01-01 DANOVA M ;AGLIETTA M
UN DATABASE PER L’ANEMIA DI DIAMOND-BLACKFAN
2010-01-01 Boria I; Garelli E; Quarello P;Aspesi A; Carando A; Lorenzati A; Ansaldi G; Davitto M; Dianzani I; Ramenghi U
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging
2010-01-01 E. Messa;S. Carturan;C. Maffe;M. Pautasso;E. Bracco;A. Roetto;F. Messa;F. Arruga;I. Defilippi;V. Rosso;C. Zanone;A. Rotolo;E. Greco;R. M. Pellegrino;D. Alberti;G. Saglio;D. Cilloni
Diamond-Blackfan anemia: a congenital defect in erythropoiesis
1996-01-01 DIANZANI I; GARELLI E; U. RAMENGHI
Diamond-Blackfan anemia: genotype-phenotype correlation in Italian patients with RPL5 and RPL11 mutations
2010-01-01 Quarello P; Garelli E; Carando A; Brusco A; Calabrese R; Dufour C; Longoni D; Misuraca A; Vinti L; Aspesi A; Biondini L; Loreni F; Dianzani I; Ramenghi U
Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease
2015-01-01 Kalish, Brian T; Matte, Alessandro; Andolfo, Immacolata; Iolascon, Achille; Weinberg, Olga; Ghigo, Alessandra; Cimino, James; Siciliano, Angela; Hirsch, Emilio; Federti, Enrica; Puder, Mark; Brugnara, Carlo; De Franceschi, Lucia
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML.
1991-01-01 GUERRASIO A; MARTINELLI G; AMBROSETTI A; FALDA M; PAOLINO F; REGECAMBRIN G; ROSSO C; PIGNATTI PF; GASPARINI P; PERONA G; RESEGOTTI L; SAGLIO G
Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells.
1991-01-01 PIACIBELLO W ;SEVERINO A ;STACCHINI A ;AGLIETTA M
Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome
2004-01-01 FERRERO D; CAMPA E; DELLACASA C; CAMPANA S; FOLI C; BOCCADORO M.
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: An Italian study
2011-01-01 Paganin, Maddalena; Pigazzi, Martina*; Bresolin, Silvia; Masetti, Riccardo; Fagioli, Franca; Chiaretti, Sabina; Cazzaniga, Giovanni; Locatelli, Franco; Pession, Andrea; te Kronnie, Geertruy; Basso, Giuseppe
Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?
1985-01-01 Pastore G; Cordero di Montezemolo L; Boschis MP; Ghibaudo P; Saracco P; Miniero R; Madon E; Forni M; Saitta M.
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.
2000-01-01 PALUMBO A; TRIOLO S; BALDINI L; CALLEA V; CAPALDI A; DE STEFANO V; GRASSO M; LIBERATI M; LOTESORIERE C; MARCENO R; MARMONT F; MUSTO P; PETRUCCI MT; SPRIANO M; PILERI A; M. BOCCADORO
Dose-intensive melphalan with stem cell support /CM regimen is effective and well tolerated in elderly myeloma patients.
2000-01-01 Palumbo A; Triolo S; Baldini L; Callea V; Capaldi A; De Stefano V; Grasso M; Liberati M; Lotesoriere C; Marcenò R; Marmont F; Musto P; Petrucci MT; Spriano M; Pileri A; Boccadoro M
Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes
2007-01-01 Skorokhod, Oleksii; Kulikova, Elena V; Galkina, Ninel M; Medvedev, Pavel V; Zybunova, Elena E; Vitvitsky, Victor M; Pivnik, Aleksandr V; Ataullakhanov, Fazoil I
DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION
2016-01-01 Fava, C; Varotto, M; Berchialla, P; Gottardi, E; Daraio, F; Lorenzatti, R; Giugliano, E; Barberio, D; Iurlo, A; Cattaneo, D; Orlandi, E; Chiara, E; Pregno, P; Nicolosi, M; Ferrero, D; Riera, L; Rege-Cambrin, G; Saglio, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Current therapeutic options for multiple myeloma. | 1996 | Pileri A; Palumbo A; Boccadoro M | |
| Current therapeutic options for multiple myeloma. | 1996 | PILERI A ;PALUMBO A ;BOCCADORO M | |
| Cyclic neutropenia and severe hypogammaglobulinemia in a patient with excess of CD8-positive T lymphocytes: response to G-CSF therapy. | 1993 | FERRERO D ;PREGNO P ;OMEDÈ P ;DIANZANI U ;CARBONE A ;DI CELLE PF ;GALLO E | |
| Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma. | 1994 | Palumbo A; Boccadoro M; Triolo S; Bruno B; Pileri A | |
| Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma. | 1994 | PALUMBO A ;BOCCADORO M ;BRUNO B ;TRIOLO S ;PILERI A | |
| Cytokine receptors, growth factors and cell cycle in human bone marrow and peripheral blood hematopoietic progenitors. | 1997 | DANOVA M ;AGLIETTA M | |
| UN DATABASE PER L’ANEMIA DI DIAMOND-BLACKFAN | 2010 | Boria I; Garelli E; Quarello P;Aspesi A; Carando A; Lorenzati A; Ansaldi G; Davitto M; Dianzani I; Ramenghi U | |
| Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging | 2010 | E. Messa;S. Carturan;C. Maffe;M. Pautasso;E. Bracco;A. Roetto;F. Messa;F. Arruga;I. Defilippi;V. Rosso;C. Zanone;A. Rotolo;E. Greco;R. M. Pellegrino;D. Alberti;G. Saglio;D. Cilloni | |
| Diamond-Blackfan anemia: a congenital defect in erythropoiesis | 1996 | DIANZANI I; GARELLI E; U. RAMENGHI | |
| Diamond-Blackfan anemia: genotype-phenotype correlation in Italian patients with RPL5 and RPL11 mutations | 2010 | Quarello P; Garelli E; Carando A; Brusco A; Calabrese R; Dufour C; Longoni D; Misuraca A; Vinti L; Aspesi A; Biondini L; Loreni F; Dianzani I; Ramenghi U | |
| Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease | 2015 | Kalish, Brian T; Matte, Alessandro; Andolfo, Immacolata; Iolascon, Achille; Weinberg, Olga; Ghigo, Alessandra; Cimino, James; Siciliano, Angela; Hirsch, Emilio; Federti, Enrica; Puder, Mark; Brugnara, Carlo; De Franceschi, Lucia | |
| Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML. | 1991 | GUERRASIO A; MARTINELLI G; AMBROSETTI A; FALDA M; PAOLINO F; REGECAMBRIN G; ROSSO C; PIGNATTI PF; GASPARINI P; PERONA G; RESEGOTTI L; SAGLIO G | |
| Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells. | 1991 | PIACIBELLO W ;SEVERINO A ;STACCHINI A ;AGLIETTA M | |
| Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome | 2004 | FERRERO D; CAMPA E; DELLACASA C; CAMPANA S; FOLI C; BOCCADORO M. | |
| DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: An Italian study | 2011 | Paganin, Maddalena; Pigazzi, Martina*; Bresolin, Silvia; Masetti, Riccardo; Fagioli, Franca; Chiaretti, Sabina; Cazzaniga, Giovanni; Locatelli, Franco; Pession, Andrea; te Kronnie, Geertruy; Basso, Giuseppe | |
| Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy? | 1985 | Pastore G; Cordero di Montezemolo L; Boschis MP; Ghibaudo P; Saracco P; Miniero R; Madon E; Forni M; Saitta M. | |
| Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients. | 2000 | PALUMBO A; TRIOLO S; BALDINI L; CALLEA V; CAPALDI A; DE STEFANO V; GRASSO M; LIBERATI M; LOTESORIERE C; MARCENO R; MARMONT F; MUSTO P; PETRUCCI MT; SPRIANO M; PILERI A; M. BOCCADORO | |
| Dose-intensive melphalan with stem cell support /CM regimen is effective and well tolerated in elderly myeloma patients. | 2000 | Palumbo A; Triolo S; Baldini L; Callea V; Capaldi A; De Stefano V; Grasso M; Liberati M; Lotesoriere C; Marcenò R; Marmont F; Musto P; Petrucci MT; Spriano M; Pileri A; Boccadoro M | |
| Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes | 2007 | Skorokhod, Oleksii; Kulikova, Elena V; Galkina, Ninel M; Medvedev, Pavel V; Zybunova, Elena E; Vitvitsky, Victor M; Pivnik, Aleksandr V; Ataullakhanov, Fazoil I | |
| DROPLED DIGITAL PCR MAY HAVE A PROGNOSTIC VALUE FOR PREDICTING RELAPSE AFTER IMATINIB DISCONTINUATION | 2016 | Fava, C; Varotto, M; Berchialla, P; Gottardi, E; Daraio, F; Lorenzatti, R; Giugliano, E; Barberio, D; Iurlo, A; Cattaneo, D; Orlandi, E; Chiara, E; Pregno, P; Nicolosi, M; Ferrero, D; Riera, L; Rege-Cambrin, G; Saglio, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile